Medical device manufacturer Medeologix has partnered with Biocoat to expand its end-to-end catheter solutions by adding hydrophilic coating services.
Biocoat is a full-service coatings provider specialising in lubricious hydrophilic coatings tailored to meet specific clinical parameters for medical devices.
In addition, the company provides polymer services and coating application assistance to support medical device manufacturing, helping companies optimise performance and streamline production processes.
It also has established US Food and Drug Administration (FDA) master files to help in streamlining regulatory approvals.
The collaboration aims to support Medeologix in delivering coating solutions for advanced catheter technologies.
Medeologix partners with clients to provide a one-stop-shop service for the medical device industry, spanning from concept to mass production.
Its services include in-house extrusion, medical balloon forming, complex catheter manufacturing, PET heat shrink tubing, over-moulding, secondary operations, and finished device solutions.
The addition of hydrophilic coating services further strengthens Medeologix’s one-stop-shop offering for catheter development and manufacturing.
With a vertically integrated approach, the company incorporates hydrophilic coating into the catheter processing workflow, improving efficiency, quality, and cost-effectiveness for clients.
Medeologix chief development officer Albert Weng said: “It allows us to offer our clients not just speed and efficiency, but also the assurance of working with industry-leading coating materials backed by robust regulatory support.
“By integrating hydrophilic coating services into our existing catheter production line, we deliver lightning-fast solutions with unprecedented efficiency.
“This advancement allows us to offer our clients in the Bay Area and beyond an unparalleled combination of speed and consistency.”
Other key benefits of Medeologix’s expanded services include a proximity advantage, enabling faster local solutions with minimal delays.
The streamlined production process accelerates time-to-market for new catheter designs.
With enhanced quality control, the medical device manufacturer provides end-to-end oversight of the manufacturing process.
The company also offers cost efficiency by reducing the need for multiple vendors.
Additionally, customisable coating solutions are available to meet specific performance requirements.
